Birdwood Therapeutics
Birdwood is a biotech startup pioneering a new class of small molecule drugs that can rewire biology through induced proximity. They are building an innovative discovery engine to explore mechanisms beyond traditional chemistry, aiming to target complex diseases. The company is looking for a scientist to help develop their high-throughput screening platform and advance their early-stage programs.
Birdwood Therapeutics is a biotechnology company developing precision medicines to address high unmet medical needs. The company combines target discovery, translational biology, and medicinal chemistry with a proprietary discovery platform to advance small‑molecule and biologic candidates from preclinical research into clinical development. Birdwood focuses on complex diseases with limited treatment options and aims to deliver therapies that improve patient outcomes. It partners with academic centers and industry collaborators to accelerate development and clinical translation.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Birdwood Therapeutics.